SEC Form D · filed March 15, 2019
INNOVATE BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Roy K. Proujansky · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorSaira K. Ramasastry · Raleigh, NCDirectorAnthony Maida · Raleigh, NCDirectorLorin K. Johnson · Raleigh, NCDirectorJay P. Madan · Raleigh, NCExec · DirectorRyan Belanger-Saleh · New York, NYDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorJohn Bykowski · Hayward, CAExec · DirectorScott Zeilinger · New York, NYExec · DirectorArnar Agnarsson · Bozeman, MTDirectorJeffrey Myers · New York, NYDirectorKevin Cavenaugh · Portland, ORExec · DirectorLorne Thomas · Odessa, FLExec · DirectorWilliam P. Corry · Sewickley, PADirectorChristopher Long · Mission Woods, KSDirectorShinji Kim · SAN FRANCISCO, CADirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗